UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000028905 |
|---|---|
| Receipt number | R000033078 |
| Scientific Title | A multicenter, phase 3 study assessing efficacy and safety of the Sirolimus in the Treatment of intractable lymphatic anomalies (SILA study) |
| Date of disclosure of the study information | 2017/08/30 |
| Last modified on | 2021/03/02 12:55:58 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/08/30 14:51:15 | ||
| 2 | Update | 2017/08/30 14:55:05 | Date of disclosure of the study information |
|
| 3 | Update | 2017/08/31 16:59:27 | Public title Public title |
|
| 4 | Update | 2017/11/07 09:58:39 | Recruitment status |
|
| 5 | Update | 2019/09/25 14:27:33 | Recruitment status Date of IRB |
|
| 6 | Update | 2021/03/02 12:55:58 | Recruitment status Last follow-up date |
